Acteoside Counteracts Interleukin-1<i>β</i>-Induced Catabolic Processes through the Modulation of Mitogen-Activated Protein Kinases and the NF<i>κ</i>B Cellular Signaling Pathway

<div>Acteoside suppresses MAPK and NF<i>κ</i>B phosphorylation in primary rat chondrocytes treated with IL-1<i>β</i>. Primary rat chondrocytes were treated with 50 and 100 <i>μ</i>M acteoside in the presence or absence of 10 ng/mL IL-1<i>β</i> for 24 h. Thereafter, total proteins were extracted to perform western blot using MAPK and NF<i>κ</i>B antibody.</div>

Oxidative Medicine and Cellular Longevity

fig7

Figure 7

Figure 7: Acteoside Counteracts Interleukin-1<i>β</i>-Induced Catabolic Processes through the Modulation of Mitogen-Activated Protein Kinases and the NF<i>κ</i>B Cellular Signaling Pathway 

Figure 7 | Acteoside Counteracts Interleukin-1β-Induced Catabolic Processes through the Modulation of Mitogen-Activated Protein Kinases and the NFκB Cellular Signaling Pathway 